Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Androsterone glucuronide to dehydroepiandrosterone sulphate ratio is discriminatory for obese Caucasian women with polycystic ovary syndrome.

Cho LW, Sathyapalan T, Kilpatrick ES, Keevil BG, Miller AG, Coady AM, Ahmed L, Atkin SL.

BMC Endocr Disord. 2017 May 19;17(1):26. doi: 10.1186/s12902-017-0177-3.

2.
3.

Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS).

Kumar A, Woods KS, Bartolucci AA, Azziz R.

Clin Endocrinol (Oxf). 2005 Jun;62(6):644-9.

PMID:
15943823
4.

Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.

Yilmaz SA, Kerimoglu OS, Pekin AT, Incesu F, Dogan NU, Celik C, Unlu A.

Eur J Obstet Gynecol Reprod Biol. 2014 Sep;180:56-60. doi: 10.1016/j.ejogrb.2014.06.004. Epub 2014 Jun 13.

PMID:
25020276
5.

Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases.

Kiddy DS, Sharp PS, White DM, Scanlon MF, Mason HD, Bray CS, Polson DW, Reed MJ, Franks S.

Clin Endocrinol (Oxf). 1990 Feb;32(2):213-20.

PMID:
2112067
6.

24-hour serum cortisol profiles in women with polycystic ovary syndrome.

Prelević GM, Würzburger MI, Balint-Perić L.

Gynecol Endocrinol. 1993 Sep;7(3):179-84.

PMID:
8291455
7.

Anti-Müllerian Hormone and Inhibin-A, but not Inhibin-B or Insulin-Like Peptide-3, may be Used as Surrogates in the Diagnosis of Polycystic Ovary Syndrome in Adolescents: Preliminary Results.

Yetim A, Yetim Ç, Baş F, Erol OB, Çığ G, Uçar A, Darendeliler F.

J Clin Res Pediatr Endocrinol. 2016 Sep 1;8(3):288-97. doi: 10.4274/jcrpe.3253. Epub 2016 Apr 29.

8.

Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents.

Silfen ME, Denburg MR, Manibo AM, Lobo RA, Jaffe R, Ferin M, Levine LS, Oberfield SE.

J Clin Endocrinol Metab. 2003 Oct;88(10):4682-8.

PMID:
14557441
9.

Association of MEP1A gene variants with insulin metabolism in central European women with polycystic ovary syndrome.

Lam UD, Lerchbaum E, Schweighofer N, Trummer O, Eberhard K, Genser B, Pieber TR, Obermayer-Pietsch B.

Gene. 2014 Mar 10;537(2):245-52. doi: 10.1016/j.gene.2013.12.055. Epub 2014 Jan 2.

PMID:
24388959
10.

Heterogenous origins of hyperandrogenism in the polycystic ovary syndrome in relation to body mass index and insulin resistance.

Patlolla S, Vaikkakara S, Sachan A, Venkatanarasu A, Bachimanchi B, Bitla A, Settipalli S, Pathiputturu S, Sugali RN, Chiri S.

Gynecol Endocrinol. 2018 Mar;34(3):238-242. doi: 10.1080/09513590.2017.1393062. Epub 2017 Oct 25.

PMID:
29068242
11.

Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome.

Panidis D, Rousso D, Koliakos G, Kourtis A, Katsikis I, Farmakiotis D, Votsi E, Diamanti-Kandarakis E.

Fertil Steril. 2006 Jun;85(6):1778-83. Epub 2006 May 2.

PMID:
16650418
12.

Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.

Ardawi MS, Rouzi AA.

Fertil Steril. 2005 Jun;83(6):1708-16.

PMID:
15950640
13.

Measurement of selected androgens using liquid chromatography-tandem mass spectrometry in reproductive-age women with Type 1 diabetes.

Gunness A, Pazderska A, Ahmed M, McGowan A, Phelan N, Boran G, Taylor AE, O'Reilly MW, Arlt W, Moore K, Behan LA, Sherlock M, Gibney J.

Hum Reprod. 2018 Sep 1;33(9):1727-1734. doi: 10.1093/humrep/dey243.

PMID:
30020477
14.

Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome.

Fenkci SM, Fenkci V, Oztekin O, Rota S, Karagenc N.

Hum Reprod. 2008 Jul;23(7):1602-6. doi: 10.1093/humrep/den109. Epub 2008 Mar 31.

PMID:
18378560
15.

Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.

Daan NM, Jaspers L, Koster MP, Broekmans FJ, de Rijke YB, Franco OH, Laven JS, Kavousi M, Fauser BC.

Hum Reprod. 2015 Oct;30(10):2376-86. doi: 10.1093/humrep/dev195. Epub 2015 Aug 12.

PMID:
26269538
16.

Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.

Singh S, Akhtar N, Ahmad J.

Diabetes Metab Syndr. 2012 Oct-Dec;6(4):207-11. doi: 10.1016/j.dsx.2012.05.013. Epub 2012 Jul 6.

PMID:
23199540
17.

Opposing effects of dehydroepiandrosterone sulfate and free testosterone on metabolic phenotype in women with polycystic ovary syndrome.

Lerchbaum E, Schwetz V, Giuliani A, Pieber TR, Obermayer-Pietsch B.

Fertil Steril. 2012 Nov;98(5):1318-25.e1. doi: 10.1016/j.fertnstert.2012.07.1057. Epub 2012 Jul 24.

PMID:
22835450
18.

Androsterone sulfate: physiology and clinical significance in hirsute women.

Zwicker H, Rittmaster RS.

J Clin Endocrinol Metab. 1993 Jan;76(1):112-6.

PMID:
8380602
19.

Comparison of adrenocortical steroidogenesis in women with post-adolescent severe acne and polycystic ovary syndrome.

Cinar N, Cetinozman F, Aksoy DY, Elcin G, Yildiz BO.

J Eur Acad Dermatol Venereol. 2015 May;29(5):875-80. doi: 10.1111/jdv.12696. Epub 2014 Aug 29.

PMID:
25176476
20.

High DHEAS/free testosterone ratio is related to better metabolic parameters in women with PCOS.

Güdücü N, Kutay SS, Görmüş U, Kavak ZN, Dünder İ.

Gynecol Endocrinol. 2015 Jun;31(6):495-500. doi: 10.3109/09513590.2015.1022862. Epub 2015 May 19.

PMID:
25986306

Supplemental Content

Support Center